Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 9,002 Castle Biosciences, Inc. shares (Form 4)

Traded Jul 27, 2026 · Filed Jul 29, 2026

On Jul 27, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 9,002 Castle Biosciences, Inc. shares at an average US$24.16 for US$218K under a trading plan, leaving 11,812 shares. Filed Jul 29, 2026 (Form 4).

Sold
9,002 shares
Price
US$24.16 average (US$24.13 to US$25.06)
Value
US$218K
Holding after
11,812 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 27, 2026Common StockOption exercise6,214US$2.3927,693Direct
Jul 27, 2026Common StockSale5,982US$24.1321,711Direct
Jul 27, 2026Common StockSale1,307US$24.1338,046Indirect
Jul 27, 2026Common StockSale1,110US$24.1332,339Indirect
Jul 27, 2026Common StockSale268US$24.1311,822Indirect
Jul 27, 2026Common StockSale232US$25.0621,479Direct
Jul 27, 2026Common StockSale50US$25.0637,996Indirect
Jul 27, 2026Common StockSale43US$25.0632,296Indirect
Jul 27, 2026Common StockSale10US$25.0611,812Indirect

Source

View original at SEC

Related